Plain-English translation of NCT06376734 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Major Depressive Disorder research guide โPhase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing transcranial magnetic stimulation (TMS) โ a non-invasive procedure that uses magnetic pulses to stimulate specific areas of the brain โ to see which brain locations work best for treating mental health conditions like depression, anxiety, obsessive-compulsive disorder, and schizophrenia. Researchers will give you TMS treatment at two different locations in your brain (with a 2-month break between them) to figure out which target helps the most. Everyone in this study receives active treatment, not placebo.
Current TMS treatments help some people with mental health conditions, but doctors don't yet know which specific brain locations are most effective for different conditions. This trial aims to map out the best targets so that future TMS treatment can be more personalized and successful.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will visit the research center for brain imaging and behavioral testing before your first treatment session, then receive 2 days of intensive magnetic stimulation (about 20 treatments total) at one brain location. After a 2-month break, you'll return for the same testing and another 2 days of treatment at a different brain location. Each testing session takes about 6 hours spread over two days, though you can sometimes complete it in one day instead. Throughout the study, you'll work with the research team and your regular mental health provider.
AI-generated summary from trial data ยท Jul 19, 2026 ยท Not medical advice
United States